BN Business News
Add your company to Business Communicator →

Business · 21/05/2018Updated: 10/17/2026 · 1 min read

FDA Announces Draft Guidance for Developing CMV Drugs for Transplant Patients

Summary

The FDA is releasing a draft guidance to help pharmaceutical companies develop medications to treat or prevent cytomegalovirus disease in patients who have undergone solid organ or hematopoietic stem cell transplants.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →